Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

KRBP Kiromic BioPharma Inc

0,60

0,00 (0,00%)

16 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Kiromic BioPharma (NASDAQ:KRBP)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Kiromic BioPharma Charts.

Kiromic BioPharma (NASDAQ:KRBP)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Kiromic BioPharma Charts.

News Kiromic BioPharma Inc

Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients
Mittwoch 24 April 2024 (3 Wochen vor) • Business Wire

Form 8-K - Current report
Freitag 19 April 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Mittwoch 10 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 5 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 2 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
Dienstag 2 April 2024 (1 Monat vor) • Business Wire

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Donnerstag 21 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 20 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 20 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial
Dienstag 19 März 2024 (2 Monate vor) • Business Wire

Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Freitag 1 März 2024 (3 Monate vor) • Business Wire

Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
Donnerstag 29 Februar 2024 (3 Monate vor) • Business Wire

Weitere Kiromic BioPharma Inc News-Artikel

PETRR44 Ex:41,21

Abn Amro Bank 1.485% 23m...

Van Eyk Blueprint Alternatives P

Invesco S&P 500 UCITS ET...

Jpmorgan Chase Bank Na P...

State Street Global Advi...

Vontobel Financial Produ...

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen